Serum uric acid lowering and effects of sodium‐glucose cotransporter‐2 inhibitors on gout: A meta‐analysis and meta‐regression of randomized controlled trials

医学 痛风 内科学 危险系数 达帕格列嗪 荟萃分析 恩帕吉菲 安慰剂 随机对照试验 卡格列净 尿酸 置信区间 相对风险 2型糖尿病 糖尿病 内分泌学 替代医学 病理
作者
Mainak Banerjee,Rimesh Pal,Indira Maisnam,Subhankar Chowdhury,Satinath Mukhopadhyay
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:25 (9): 2697-2703 被引量:22
标识
DOI:10.1111/dom.15157
摘要

Abstract Aims To pool the effects of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors on gout and to investigate the association of these effects with baseline serum uric acid (SUA), SUA lowering, and underlying conditions, such as type 2 diabetes mellitus (T2DM)/heart failure (HF). Methods PubMed, Embase, Web of Science, Cochrane Library and clinical trial registry websites were searched for randomized controlled trials (RCTs) or post hoc analyses (≥1‐year duration; PROSPERO:CRD42023418525). The primary outcome was a composite of gouty arthritis/gout flares and commencement of anti‐gout drugs (SUA‐lowering drugs/colchicine). Hazard ratios (HRs) with 95% confidence interval (CI) were pooled using a generic inverse‐variance method with a random‐effects model. Mixed‐effects model univariate meta‐regression analysis was performed. Results Five RCTs involving 29 776 patients (T2DM, n = 23 780) and 1052 gout‐related events were identified. Compared to placebo, SGLT2 inhibitor use was significantly associated with reduced risk of composite gout outcomes (HR 0.55, 95% CI 0.45‐0.67; I 2 = 61%, P < 0.001). Treatment benefits did not differ between trials being conducted exclusively in baseline HF versus those conducted in patients with T2DM ( P ‐interaction = 0.37), but were greater with dapagliflozin 10 mg and canagliflozin 100/300 mg ( P < 0.01 for subgroup differences). Sensitivity analysis excluding trials that evaluated the effects of empagliflozin 10/25 mg (HR 0.68, 95% CI 0.57‐0.81; I 2 = 0%) accentuated the benefits of SGLT2 inhibitors with no between‐trial heterogeneity (HR 0.46, 95% CI 0.39‐0.55; I 2 = 0%). Univariate meta‐regression found no impact of baseline SUA, SUA lowering on follow‐up, diuretic use, or other variables on their anti‐gout effects. Conclusion We found that SGLT2 inhibitors significantly reduced the risk of gout in individuals with T2DM/HF. Lack of an association with SUA‐lowering effects suggests that metabolic and anti‐inflammatory effects of SGLT2 inhibitors may predominantly mediate their anti‐gout benefits.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ting发布了新的文献求助10
刚刚
忧虑的慕山完成签到,获得积分10
1秒前
qian完成签到 ,获得积分10
1秒前
科研小白完成签到,获得积分10
1秒前
ele_yuki完成签到,获得积分10
2秒前
夜雨完成签到,获得积分10
2秒前
3秒前
YamDaamCaa应助N0V1CE采纳,获得50
4秒前
田様应助HelloKun采纳,获得10
4秒前
5秒前
覃纪隆完成签到,获得积分10
6秒前
7秒前
Leukocyte完成签到 ,获得积分10
7秒前
量子星尘发布了新的文献求助10
8秒前
宇宙第一帅完成签到,获得积分10
8秒前
墨菲特关注了科研通微信公众号
8秒前
8秒前
10秒前
SXYYXS完成签到 ,获得积分10
11秒前
12秒前
12秒前
ClaudiaCY发布了新的文献求助10
13秒前
candy发布了新的文献求助10
13秒前
豆芽完成签到,获得积分10
13秒前
pluto应助wml采纳,获得10
14秒前
iui飞完成签到,获得积分10
14秒前
14秒前
IyGnauH完成签到 ,获得积分10
15秒前
15秒前
17秒前
小巧的虔发布了新的文献求助10
17秒前
iui飞发布了新的文献求助10
17秒前
科研通AI2S应助jiang采纳,获得10
17秒前
小青龙完成签到,获得积分10
18秒前
ws完成签到,获得积分20
19秒前
19秒前
天天快乐应助1234采纳,获得10
20秒前
PRIPRO发布了新的文献求助10
20秒前
萧萧完成签到,获得积分10
20秒前
Akim应助小小小何77采纳,获得10
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance 500
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969940
求助须知:如何正确求助?哪些是违规求助? 3514642
关于积分的说明 11175298
捐赠科研通 3249947
什么是DOI,文献DOI怎么找? 1795178
邀请新用户注册赠送积分活动 875617
科研通“疑难数据库(出版商)”最低求助积分说明 804891